血糖控制对糖尿病患者的白内障手术至关重要吗？
Is glycaemic control essential for cataract surgery among patients with diabetes mellitus?
作者信息
C Ramachandra Himateja, T Sangeetha, N Inchara
机构信息
Department of Ophthalmology, Sri Devaraj Urs Medical college,Tamaka, Kolar, Karnataka, India.
出版信息
Bioinformation. 2025 May 31;21(5):1011-1015. doi: 10.6026/973206300211011. eCollection 2025.
Abstract
Diabetic patients are at increased risk of cataracts, with higher risks of intraoperative and postoperative complications. Therefore, it is of interest to explore the challenges in performing cataract surgery on diabetic patients. Hence, a prospective study of 300 Type II diabetes patients undergoing cataract surgery found that 69.3% achieved post-operative visual acuity of 6/18 or better. Common complications included iritis (9.7%) and striate keratopathy (7.7%). The severity of diabetic retinopathy, diabetic macular edema, and poor preoperative visual acuity were linked to worse postoperative outcomes. Intravitreal steroids may improve outcomes in patients with diabetic macular edema.
摘要
糖尿病患者患白内障的风险增加，术中及术后并发症风险更高。因此，探讨对糖尿病患者进行白内障手术的挑战具有重要意义。因此，一项对300例接受白内障手术的II型糖尿病患者的前瞻性研究发现，69.3%的患者术后视力达到6/18或更好。常见并发症包括虹膜炎（9.7%）和条纹状角膜病变（7.7%）。糖尿病视网膜病变的严重程度、糖尿病黄斑水肿和术前视力差与术后预后较差有关。玻璃体内注射类固醇可能改善糖尿病黄斑水肿患者的预后。
相似文献
1
Is glycaemic control essential for cataract surgery among patients with diabetes mellitus?血糖控制对糖尿病患者的白内障手术至关重要吗？
Bioinformation. 2025 May 31;21(5):1011-1015. doi: 10.6026/973206300211011. eCollection 2025.
2
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.预防性使用非甾体抗炎药预防白内障手术后黄斑水肿。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD006683. doi: 10.1002/14651858.CD006683.pub3.
3
How does diabetes shape the landscape of cataract development and surgical success? a systematic review and meta-analysis.糖尿病如何影响白内障的发展态势及手术成功率？一项系统综述与荟萃分析。
Endocrine. 2025 Aug 7. doi: 10.1007/s12020-025-04374-w.
4
Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.抗血管内皮生长因子联合玻璃体内注射类固醇治疗糖尿病性黄斑水肿。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD011599. doi: 10.1002/14651858.CD011599.pub2.
5
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病视网膜病变的比较：系统评价与经济分析
Health Technol Assess. 2025 May 7:1-16. doi: 10.3310/KRWP1264.
6
Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia.多焦点人工晶状体与白内障摘除术后老视患者的双焦点人工晶状体比较。
Cochrane Database Syst Rev. 2023 Jan 27;1(1):CD012648. doi: 10.1002/14651858.CD012648.pub3.
7
Risk factors and incidence of Macular Edema in eyes with retinal Vein Occlusion after uneventful cataract surgery: The MEVO study.白内障手术平稳进行后视网膜静脉阻塞患者眼中黄斑水肿的危险因素及发生率：MEVO研究
Indian J Ophthalmol. 2025 Jun 1;73(6):864-869. doi: 10.4103/IJO.IJO_1700_24. Epub 2025 Apr 17.
8
Fenofibrate for diabetic retinopathy.非诺贝特治疗糖尿病性视网膜病变。
Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2.
9
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
10
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
本文引用的文献
1
Glycemic control and macular edema in patients undergoing cataract surgery.白内障手术患者的血糖控制与黄斑水肿
Prim Care Diabetes. 2023 Feb;17(1):55-59. doi: 10.1016/j.pcd.2022.12.004. Epub 2023 Jan 2.
2
Outcomes of Cataract Surgery in Diabetic Patients in King Abdulaziz Medical City in 2019.2019年阿卜杜勒阿齐兹国王医疗城糖尿病患者白内障手术的结果
Cureus. 2022 Oct 12;14(10):e30216. doi: 10.7759/cureus.30216. eCollection 2022 Oct.
3
Visual acuity outcomes after cataract surgery in type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study.2 型糖尿病患者白内障手术后的视力结果：心血管风险控制行动中的糖尿病研究 (ACCORD)。
Br J Ophthalmol. 2022 Nov;106(11):1496-1502. doi: 10.1136/bjophthalmol-2020-317793. Epub 2021 Jun 18.
4
Visual Acuity Outcomes after Cataract Extraction with Intraocular Lens Implantation in Eyes with Diabetic Retinopathy.糖尿病视网膜病变患者白内障摘除联合人工晶状体植入术后视力结果。
Ophthalmol Retina. 2020 Apr;4(4):351-360. doi: 10.1016/j.oret.2019.12.018. Epub 2020 Jan 7.
5
Cataract in diabetes mellitus.糖尿病性白内障
World J Diabetes. 2019 Mar 15;10(3):140-153. doi: 10.4239/wjd.v10.i3.140.
6
Transepithelial photorefractive intrastromal corneal crosslinking versus photorefractive keratectomy in low myopia.经上皮准分子激光角膜光折射性间质内交联术与准分子激光角膜切削术治疗低度近视的比较。
J Cataract Refract Surg. 2019 Apr;45(4):427-436. doi: 10.1016/j.jcrs.2018.11.008. Epub 2019 Feb 4.
7
Visual outcomes after cataract surgery in patients with type 2 diabetes.2 型糖尿病患者白内障手术后的视力结果。
J Cataract Refract Surg. 2019 Apr;45(4):404-413. doi: 10.1016/j.jcrs.2018.11.002. Epub 2019 Jan 9.
8
Cataract surgery in diabetes mellitus: A systematic review.糖尿病患者的白内障手术：系统评价。
Indian J Ophthalmol. 2018 Oct;66(10):1401-1410. doi: 10.4103/ijo.IJO_1158_17.
9
Visual outcome after phacoemulsification with lens implant in diabetic and non-diabetic patients; A comparative study.糖尿病患者和非糖尿病患者白内障超声乳化联合人工晶状体植入术后的视力结果；一项对比研究。
Pak J Med Sci. 2017 May-Jun;33(3):691-694. doi: 10.12669/pjms.333.12589.
10
The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema.英国糖尿病视网膜病变电子病历（UK DR EMR）用户组，报告2：白内障手术对糖尿病性黄斑水肿影响的真实世界数据。
Br J Ophthalmol. 2017 Dec;101(12):1673-1678. doi: 10.1136/bjophthalmol-2016-309838. Epub 2017 May 9.
Zotero 插件